Sinohealth Technology Holdings SEHK 2361 Margin Compression Challenges Bullish Healthcare Digitalization Narrative

Simply Wall St.03-29

Sinohealth Technology Holdings (SEHK:2361) has put fresh numbers on the table for FY 2025, reporting first half revenue of ¥147.9 million, basic EPS of ¥0.06 and net income excluding extra items of ¥...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2623335549?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","is_english":true,"pubTime":"2026-03-29 05:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623335549","market":"us","top_or_hot":-1,"title":"Sinohealth Technology Holdings SEHK 2361 Margin Compression Challenges Bullish Healthcare Digitalization Narrative","media":"Simply Wall St.","content":"<div>\n<p>Sinohealth Technology Holdings (SEHK:2361) has put fresh numbers on the table for FY 2025, reporting first half revenue of ¥147.9 million, basic EPS of ¥0.06 and net income excluding extra items of ¥...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-2361/sinohealth-technology-holdings-shares/news/sinohealth-technology-holdings-sehk-2361-margin-compression\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinohealth Technology Holdings SEHK 2361 Margin Compression Challenges Bullish Healthcare Digitalization Narrative</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinohealth Technology Holdings SEHK 2361 Margin Compression Challenges Bullish Healthcare Digitalization Narrative\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-29 05:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/healthcare/hkg-2361/sinohealth-technology-holdings-shares/news/sinohealth-technology-holdings-sehk-2361-margin-compression><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Sinohealth Technology Holdings (SEHK:2361) has put fresh numbers on the table for FY 2025, reporting first half revenue of ¥147.9 million, basic EPS of ¥0.06 and net income excluding extra items of ¥...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-2361/sinohealth-technology-holdings-shares/news/sinohealth-technology-holdings-sehk-2361-margin-compression\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XBI","symbol_name":"SPDR S&P Biotech ETF","start_time":0,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2361/sinohealth-technology-holdings-shares/news/sinohealth-technology-holdings-sehk-2361-margin-compression","article_id":"2623335549","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2361/sinohealth-technology-holdings-shares/news/sinohealth-technology-holdings-sehk-2361-margin-compression","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2623335549","pubTimestamp":1774732203,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Sinohealth Technology Holdings (SEHK:2361) has put fresh numbers on the table for FY 2025, reporting first half revenue of ¥147.9 million, basic EPS of ¥0.06 and net income excluding extra items of ¥24.7 million. These figures sit against a trailing 12 month picture that includes a 22.3% net profit margin and lower earnings versus the prior year. Over recent reporting periods the company has seen revenue move from ¥159.5 million in 1H 2024 to ¥244.2 million in 2H 2024 and then to ¥147.9...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"XBI":"SPDR S&P Biotech ETF","BLSX":"Tradr 2X Long BLSH Daily ETF","LABU":"三倍做多标普生物-Direxion","BK4137":"综合支持服务","BK4588":"碎股","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","BK4585":"ETF&股票定投概念","BK4112":"金融交易所和数据","02361":"中康科技控股","BLSG":"2倍做多BLSH ETF-Leverage Shares","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4581":"高盛持仓","BK1189":"医疗保健技术"},"translate_title":"Sinohealth Technology Holdings SEHK 2361利润率压缩挑战看涨医疗数字化叙事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLSX":0.6,"XBI":0.6,"BLSG":0.6,"LABU":0.6,"02361":1.97},"content_text":"Sinohealth Technology Holdings (SEHK:2361) has put fresh numbers on the table for FY 2025, reporting first half revenue of ¥147.9 million, basic EPS of ¥0.06 and net income excluding extra items of ¥24.7 million. These figures sit against a trailing 12 month picture that includes a 22.3% net profit margin and lower earnings versus the prior year. Over recent reporting periods the company has seen revenue move from ¥159.5 million in 1H 2024 to ¥244.2 million in 2H 2024 and then to ¥147.9 million in 1H 2025. Basic EPS shifted from ¥0.10 to ¥0.17 and then to ¥0.06, alongside trailing 12 month EPS of ¥0.21 and net income of ¥93.4 million. Investors are now weighing this earnings update through the lens of compressed margins and a mixed profitability trend. See our full analysis for Sinohealth Technology Holdings. With the latest figures reported, the next step is to see how these results line up with the prevailing stories around Sinohealth Technology Holdings and where the numbers start to challenge or support those views. Curious how numbers become stories that shape markets? Explore Community Narratives SEHK:2361 Earnings & Revenue History as at Mar 2026 AdvertisementMargins Slip From 27.4% To 22.3%  Over the last 12 months, net profit margin was 22.3%, compared with 27.4% the prior year, alongside trailing net income of ¥93.4 million and basic EPS of ¥0.21. Critics highlight that this margin compression leans toward a bearish view, yet the data creates a more mixed picture:\n     The five year compound earnings growth rate of 9.8% a year sits beside the recent year on year earnings decline, so longer term growth and recent pressure are pulling in opposite directions. Trailing earnings are described as high quality even as the margin moved lower, which challenges a bearish take that weaker margins automatically mean weaker underlying profitability.    Half Year Profit Swings Stand Out  Net income excluding extra items moved from ¥41.7 million in 1H 2024 to ¥69.0 million in 2H 2024, then to ¥24.7 million in 1H 2025, with basic EPS moving in parallel from ¥0.10 to ¥0.17 and then to ¥0.06. What is surprising for a bullish angle built around healthcare digitalization is how these swings in profit sit against that wider story:\n     Bulls often point to the company’s role in healthcare data, SaaS and smart medical cloud services, yet the recent trailing twelve month earnings step down from ¥110.6 million to about ¥93.4 million suggests execution is still being tested in the numbers. At the same time, the five year earnings growth rate of 9.8% a year and a trailing twelve month revenue base of ¥419.1 million indicate the business has generated growth over a longer window, which supports parts of the bullish view even as near term profitability softens.    To see how community writers connect these swings in profitability to long term stories around the business, take a look at the Curious how numbers become stories that shape markets? Explore Community Narratives. P/E Premium And DCF Gap  The shares trade on a trailing P/E of 19.9x versus a peer average of 12.7x and an Asian Healthcare Services industry average of 22x, while a DCF fair value of HK$6.43 sits above the current HK$5.18 share price. Bears argue the higher P/E is a warning sign, but the full set of valuation figures adds more nuance:\n     The 19.9x P/E is clearly above the 12.7x peer average, which backs a bearish concern that investors are paying more than for closer comparables. However, the DCF fair value of HK$6.43 compared with the HK$5.18 market price points to a gap to that modeled value, which runs against a purely bearish view that the shares are simply expensive on all measures.    Next Steps Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Sinohealth Technology Holdings's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move. Overall, the story here is mixed enough that it is worth checking the numbers yourself and seeing how they stack up against your expectations. Then weigh that against what has investors optimistic about at least one key reward by reviewing the 1 key reward. See What Else Is Out There Compressed margins, softer recent earnings and a P/E premium versus peers suggest that you might be paying up even as profitability faces pressure. If that mix leaves you wanting a stronger value story, compare this setup with companies already screened as 239 high quality undervalued stocks and see if any fit your criteria better.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2623335549","isCrawlerRequest":true}